FDA Inspection 1218362 — GEV Co.,Ltd.
The FDA completed an inspection of GEV Co.,Ltd. on Sep 6, 2023 in Eumseong. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Sep 6, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Eumseong (Korea (the Republic of))